Canary Capital’s Staked Injective ETF Heads to Cboe

The Cboe Global Markets exchange is poised to list a new staked cryptocurrency exchange-traded fund (ETF). Canary Capital’s offering, focused on Injective, could become the third staked crypto ETF to gain approval, following similar products tracking Solana and Ether. This filing represents a significant step forward for the burgeoning staked crypto ETF market and offers investors another avenue for exposure to the rapidly evolving digital asset landscape. The approval process will now unfold, subject to regulatory review and approval before the ETF can begin trading. Stay tuned for updates on this developing story as more information becomes available.